Valid for Submission
T42.2X4S is a billable code used to specify a medical diagnosis of poisoning by succinimides and oxazolidinediones, undetermined, sequela. The code is valid for the year 2020 for the submission of HIPAA-covered transactions. The ICD-10-CM code T42.2X4S might also be used to specify conditions or terms like ethosuximide overdose, ethosuximide overdose of undetermined intent, ethosuximide poisoning of undetermined intent, phensuximide poisoning of undetermined intent, poisoning by ethosuximide, poisoning by phensuximide, etc The code is exempt from present on admission (POA) reporting for inpatient admissions to general acute care hospitals.
|Short Description:||Poisn by succinimides and oxazolidinediones, undet, sequela|
|Long Description:||Poisoning by succinimides and oxazolidinediones, undetermined, sequela|
This code was replaced in the 2020 ICD-10 code set with the code(s) listed below. The National Center for Health Statistics (NCHS) has published an update to the ICD-10-CM diagnosis codes which became effective October 1, 2019. This code was replaced for the FY 2020 (October 1, 2019 - September 30, 2020).
- K59.03 - Drug induced constipation
The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:
- Ethosuximide overdose
- Ethosuximide overdose of undetermined intent
- Ethosuximide poisoning of undetermined intent
- Phensuximide poisoning of undetermined intent
- Poisoning by ethosuximide
- Poisoning by phensuximide
- Succinimide poisoning of undetermined intent
Diagnostic Related Groups
The ICD-10 code T42.2X4S is grouped in the following groups for version MS-DRG V37.0 What are Diagnostic Related Groups?
The Diagnostic Related Groups (DRGs) are a patient classification scheme which provides a means of relating the type of patients a hospital treats. The DRGs divides all possible principal diagnoses into mutually exclusive principal diagnosis areas referred to as Major Diagnostic Categories (MDC). applicable from 10/01/2020 through 09/30/2020.
- 922 - OTHER INJURY, POISONING AND TOXIC EFFECT DIAGNOSES WITH MCC
- 923 - OTHER INJURY, POISONING AND TOXIC EFFECT DIAGNOSES WITHOUT MCC
Present on Admission (POA)
T42.2X4S is exempt from POA reporting - The Present on Admission (POA) indicator is used for diagnosis codes included in claims involving inpatient admissions to general acute care hospitals. POA indicators must be reported to CMS on each claim to facilitate the grouping of diagnoses codes into the proper Diagnostic Related Groups (DRG). CMS publishes a listing of specific diagnosis codes that are exempt from the POA reporting requirement.
CMS POA Indicator Options and Definitions
|POA Indicator Code||POA Reason for Code||CMS will pay the CC/MCC DRG?|
|Y||Diagnosis was present at time of inpatient admission.||YES|
|N||Diagnosis was not present at time of inpatient admission.||NO|
|U||Documentation insufficient to determine if the condition was present at the time of inpatient admission.||NO|
|W||Clinically undetermined - unable to clinically determine whether the condition was present at the time of inpatient admission.||YES|
|1||Unreported/Not used - Exempt from POA reporting. ||NO|
Convert T42.2X4S to ICD-9
- 909.0 - Late eff drug poisoning (Combination Flag)
- E989 - Late eff inj-undet circ (Combination Flag)
Injury, poisoning and certain other consequences of external causes (S00–T98)
Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances (T36-T50)
Antiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42)
- FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016
(First year ICD-10-CM implemented into the HIPAA code set)
- FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
- FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
- FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
- FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020